Technical guidance
A guide to WHO’s guidance
17 July 2020
Critical preparedness, readiness and response actions for COVID-19
Country-level coordination, planning, and monitoring
Serology and Early Investigation protocols
Risk communication and community engagement
Naming the coronavirus disease (COVID-19)
Surveillance, rapid response teams, and case investigation
Clinical care
Essential resource planning
Virus origin/Reducing animal-human transmission
Humanitarian operations, camps, refugees/migrants in non-camps and other fragile settings
National laboratories
Infection prevention and control / WASH
Guidance for schools, workplaces & institutions
Travel, Points of Entry and Border Health
Health workers
Maintaining Essential Health Services and Systems
Status of environmental surveillance for SARS-CoV-2 virus
COVID-19 and the use of angiotensin-converting enzyme inhibitors and receptor blockers
Estimating mortality from COVID-19
"Immunity passports" in the context of COVID-19
Transmission of SARS-CoV-2: implications for infection prevention precautions
The use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with COVID-19
Breastfeeding and COVID-19
Bacille Calmette-Guérin (BCG) vaccination and COVID-19
Criteria for releasing COVID-19 patients from isolation
Off-label use of medicines for COVID-19
Smoking and COVID-19
Advice on the use of point-of-care immunodiagnostic tests for COVID-19
Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19
Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations
